A pharmacist shares how the recently introduced Cautionary Advisory Label (CAL D) for antibiotics has changed patient perceptions, and behaviour, towards antibiotics.

The Pharmaceutical Benefits Advisory Committee has announced new ongoing arrangements for Continued Dispensing.

SABA overuse is undermining asthma control. This National Asthma Week, pharmacists should inform patients about the risks.

To increase awareness about ADHD, two pharmacists share their journey of adult diagnosis and medicine optimisation.

After years of little movement in downscheduling of medicines in Australia, 2021 will usher in a flurry of activity – but Appendix M remains conspicuously empty.

A worldwide Vyvanse, expected to last months, has left pharmacists inundated with requests for the popular ADHD medicine.